It's gone through! Obama signs Sunscreen Innovation Act

By Michelle Yeomans contact

- Last updated on GMT

It's gone through! Obama signs Sunscreen Innovation Act

Related tags: Sunscreen innovation act, Sunscreen

President Obama has signed the Sunscreen Innovation Act into law, which modifies the FDA review and approval process of over-the-counter sunscreen ingredients.

Following on from senate approval for the Sunscreen Innovation act in October, the bill has finally been signed by the President which aims to streamline the sunscreen approval regulatory process, enabling the FDA to approve new ingredients far more efficiently.

Until now the system for the approval of OTC sunscreens has been long-winded and bureaucratic, demanding ingredient providers supply a significant amount of paperwork.

The Act will ultimately help to provide Americans with access to the latest sunscreen ingredients, some of which have been widely available for 15 years in Europe, Asia and Latin America. 

That process takes around a year to secure approval but because of the lengthy process a considerable backlog has built up, which means approval is now taking much longer than that.

What does this now mean for sunscreen makers?

The current regulatory system for sunscreens was established in 2002, promulgating a two-part process which classifies such active ingredients under the OTC drug monograph system.

The backlog of ingredients includes eight that have been waiting approval for years - amiloxate, 10%; bemotrizinol, 10%; bisoctrizole, 10%; *diethylhexyl butamido triazone, 3%; drometrizole trisiloxane, 15%; ecamsule, 10%; enzacamene, 4%; *octyl triazone, 5%. 

“If the Sunscreen Innovation Act is passed, we will hopefully see these pending requests either granted or denied within the next year and a half. That, as you can imagine, is beneficial to all as more options for active ingredients will be available for use,”​ regulation law expert Angela Diesch told CosmeticsDesign-Europe.com, back in September.

Founding member of the PASS Coalition, L’Oréal USA had also released a statement prior to passing of the Bill.

“L’Oréal commends the House of Representatives for its unanimous passage of the Senate version of the Sunscreen Innovation Act (S.2141), which will provide American consumers greater access and choice when it comes to the latest and effective sunscreen products available," ​said chief communications officer, Kristina Schake.

Related topics: Regulation & Safety, Skin Care

Related news

Show more

Related products

show more

Color Change Your Life

Color Change Your Life

Tagra Biotechnologies | 11-Nov-2019 | Product Brochure

CameleonCaps™ are cellulose-based encapsulated pigments that are durable during formulation and scale-up, yet break easily beneath fingertips upon application....

SABERRY®: MULTIFACETED AND MULTITASKING

SABERRY®: MULTIFACETED AND MULTITASKING

SABINSA: Innovating the Science of Cosmetics® | 01-Nov-2019 | Technical / White Paper

Beta-glucogallin is the potent anti-aging molecule in Saberry® responsible for preventing oxidative stress and degradation of skin proteins. This patented...

Related suppliers

Follow us

Featured Events

View more

Products

View more

Webinars